AI-generated summary
The authors tested four laser wavelengths (405, 532, 635 and 808 nm) on B16F10 melanoma cells in vitro and in mice. They report that 808 nm light increased cell proliferation and migration and was associated with larger tumor volume, more blood vessel growth and higher VEGF and HIF-1α levels. The authors state that further studies are needed before PBM can be considered safe for cancer treatment.
- Who or what was studied
- B16F10 melanoma cells in vitro and melanoma tumors in mice (in vivo)
- Wavelengths
- 405, 532, 635, 808 nm
- Limits stated in the abstract
- The abstract describes only cell and animal experiments, and the molecular mechanism is stated to be unclear and requires further study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Angiogenesis, Wavelength, Oral mucositis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.